BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1437805)

  • 1. [Lupus anticoagulant--its role and significance in the pathogenesis of thrombosis].
    Styczyńska M; Chojnowski K; Matusewicz W; Krykowski E
    Pol Tyg Lek; 1992 Feb 3-10; 47(5-6):151-3. PubMed ID: 1437805
    [No Abstract]   [Full Text] [Related]  

  • 2. [Lupus anticoagulant as a risk factor of thrombosis].
    Lewandowski K; Zawilska K
    Pol Tyg Lek; 1992 Feb 3-10; 47(5-6):154-5. PubMed ID: 1437806
    [No Abstract]   [Full Text] [Related]  

  • 3. "Lupus" anticoagulant and thrombosis--possible role of inhibition of prostacyclin formation.
    Carreras LO; Vermylen JG
    Thromb Haemost; 1982 Aug; 48(1):38-40. PubMed ID: 6813993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of lupus anticoagulant and anticardiolipin antibodies with thrombosis in patients with systemic lupus erythematosus, primary antiphospholipid syndrome and other disorders.
    Brenner B; Tavori S; Lerner M; Tatarsky I; Lorber M
    Isr J Med Sci; 1992 Jan; 28(1):9-15. PubMed ID: 1733904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Thrombotic phenomena and lupus anticoagulant in a series of 112 patients with systemic lupus erythematosus].
    Ordi Ros J; Vilardell Tarrés M; Barquinero Máñez J; Selva O'Callaghan A; Alijotas Reig J; Bosch Gil J
    Rev Clin Esp; 1987 Feb; 180(2):66-70. PubMed ID: 3105004
    [No Abstract]   [Full Text] [Related]  

  • 6. [Systemic lupus erythematosus manifested by thrombophlebitis of the lower limbs].
    Olive D; André E; Brocard O; Labrude P; Alexandre P
    Arch Fr Pediatr; 1979; 36(8):807-11. PubMed ID: 539874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The lupus inhibitor].
    Carreras LO; Vermylen J
    Sangre (Barc); 1981; 26(5-A):610-8. PubMed ID: 6798699
    [No Abstract]   [Full Text] [Related]  

  • 8. [Lupus anticoagulant: an old phenomenon in a new perspective].
    Derksen RH; Kater L
    Ned Tijdschr Geneeskd; 1986 May; 130(19):849-51. PubMed ID: 3086756
    [No Abstract]   [Full Text] [Related]  

  • 9. [The anticoagulant of the lupus type: a thrombotic risk factor].
    Tobelem G
    Ann Med Interne (Paris); 1987; 138(4):243-5. PubMed ID: 3115164
    [No Abstract]   [Full Text] [Related]  

  • 10. Cerebral vein thrombosis and lupus anticoagulant antibodies.
    Marietta M; Bertesi M; Simoni L; Castelli I; Cappi C; Torelli G
    Clin Appl Thromb Hemost; 2001 Jul; 7(3):238. PubMed ID: 11441987
    [No Abstract]   [Full Text] [Related]  

  • 11. [Thrombotic manifestations and lupus anticoagulant].
    Rev Clin Esp; 1988 Mar; 182(5):286-7. PubMed ID: 3135561
    [No Abstract]   [Full Text] [Related]  

  • 12. Thromboelastography assessment of coagulation status in parturients with lupus anticoagulant receiving heparin therapy.
    Harnett M; Kodali BS
    Int J Obstet Anesth; 2006 Apr; 15(2):177-8. PubMed ID: 16488131
    [No Abstract]   [Full Text] [Related]  

  • 13. Association of lupus anticoagulant with severe valvular heart disease in systemic lupus erythematosus.
    Ford PM; Ford SE; Lillicrap DP
    J Rheumatol; 1988 Apr; 15(4):597-600. PubMed ID: 3135393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spontaneous left ventricle cavity thrombus in a patient of systemic lupus erythematosus.
    Barjatiya MK; Shah NK; Kothari SS; Shah PP; Trivedi HL
    J Assoc Physicians India; 1992 Mar; 40(3):195-6. PubMed ID: 1634487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "Lupus" anticoagulant and prostacyclin.
    Carreras LO; Vermylen J
    Lancet; 1981 Mar; 1(8221):665. PubMed ID: 6110887
    [No Abstract]   [Full Text] [Related]  

  • 16. The lupus anticoagulant in systemic lupus erythematosus.
    Rowell NR; Tate GM
    Acta Derm Venereol; 1989; 69(2):111-5. PubMed ID: 2564226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clotting defect in SLE.
    Byron MA
    Clin Rheum Dis; 1982 Apr; 8(1):137-51. PubMed ID: 6811189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lupus anticoagulant and thrombosis in systemic lupus erythematosus.
    Jungers P; Liote F; Dautzenberg MD; Gazengel C; Dougados M; Tron F; Bach JF
    Lancet; 1984 Mar; 1(8376):574-5. PubMed ID: 6142298
    [No Abstract]   [Full Text] [Related]  

  • 19. Natural anticoagulant proteins and antiphospholipid antibodies in systemic lupus erythematosus.
    Tomás JF; Alberca I; Tabernero MD; Cordero M; Del Pino-Montes J; Vicente V
    J Rheumatol; 1998 Jan; 25(1):57-62. PubMed ID: 9458203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased monocyte procoagulant activity independent of the lupus anticoagulant in patients with systemic lupus erythematosus.
    de Prost D; Ollivier V; Ternisien C; Chollet-Martin S
    Thromb Haemost; 1990 Oct; 64(2):216-21. PubMed ID: 2125372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.